STOCK TITAN

[Form 4] TERADYNE, INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Teradyne director Mercedes Johnson reported a sale of company shares under a pre-set plan and retains significant ownership. The filing shows $147.9 per share sale of 625 shares on 10/06/2025 executed under a Rule 10b5-1 sales plan. After the sale the reporting person beneficially owns 10,113 shares directly and 1,876 shares indirectly through a trust for which she is trustee and sole beneficiary. The filing identifies the sale as part of a plan adopted on 02/03/2025, and is signed by an attorney-in-fact on 10/08/2025. The transaction is presented as routine insider disposition under a documented trading plan.

La direttrice di Teradyne, Mercedes Johnson, ha riportato una vendita di azioni della società nell'ambito di un piano predefinito e mantiene una quota significativa. Il fascicolo mostra una vendita di $147.9 per azione di 625 azioni il 10/06/2025, eseguita nell'ambito di un piano di vendita Rule 10b5-1. Dopo la vendita la persona che segnala beneficia direttamente di 10,113 azioni e indirettamente di 1,876 azioni tramite un trust di cui è trustee e unico beneficiario. Il fascicolo identifica la vendita come parte di un piano adottato il 02/03/2025, ed è firmato da un procuratore in rappresentanza il 10/08/2025. L'operazione viene presentata come disposizione interna di routine nell'ambito di un piano di trading documentato.

La Directora de Teradyne, Mercedes Johnson, reportó la venta de acciones de la empresa bajo un plan preestablecido y mantiene una participación significativa. La presentación muestra la venta de $147.9 por acción de 625 acciones el 10/06/2025, realizada bajo un plan de ventas Rule 10b5-1. Después de la venta, la persona reportante posee de forma beneficiosa 10,113 acciones directamente y 1,876 acciones indirectamente a través de un fideicomiso del cual es fideicomitente y único beneficiario. El documento identifica la venta como parte de un plan adoptado el 02/03/2025, y está firmado por un apoderado en la fecha 10/08/2025. La transacción se presenta como una disposición interna de rutina bajo un plan de trading documentado.

테라다인(Teradyne)의 이사인 메르세데스 존슨(Mercedes Johnson)은 미리 정해진 계획에 따라 회사 주식을 매도했고 상당한 지분을 보유하고 있습니다. 공시는 $147.9당의 매도가 625 주로 2025-10-06에 Rule 10b5-1 매매 계획에 따라 실행되었음을 보여줍니다. 매도 후 보고자는 10,113 주를 직접 보유하고, 1,876 주를 트러스트를 통해 간접 보유하며, 그 트러스트의 수탁자이자 유일한 수익자입니다. 이 공시는 매도가 2025-02-03에 채택된 계획의 일부로 식별되며, 2025-10-08에 대리인이 서명했습니다. 이 거래는 문서화된 거래 계획에 따른 일상적 내부자 매도(disposition)로 제시됩니다.

La directrice de Teradyne, Mercedes Johnson, a signalé la vente d'actions de l'entreprise dans le cadre d'un plan prédéfini et conserve une participation importante. Le dossier indique une vente à $147.9 par action de 625 actions le 10/06/2025, réalisée dans le cadre d'un plan de vente Rule 10b5-1. Après la vente, la personne déclarant détient directement 10,113 actions et indirectement via une fiducie dont elle est fiduciaire et unique bénéficiaire 1,876 actions. Le dossier identifie la vente comme faisant partie d'un plan adopté le 02/03/2025, et elle est signée par un mandataire le 10/08/2025. La transaction est présentée comme une disposition interne routinière dans le cadre d'un plan de trading documenté.

Die Teradyne-Direktorin Mercedes Johnson berichtete über den Verkauf von Unternehmensaktien im Rahmen eines vorgegebenen Plans und behält eine bedeutende Beteiligung. Die Einreichung zeigt einen Verkauf von $147.9 pro Aktie von 625 Aktien am 10/06/2025, der im Rahmen eines Rule-10b5-1-Verkaufplans durchgeführt wurde. Nach dem Verkauf besitzt die meldende Person direkt 10,113 Aktien und indirekt über einen Trust, bei dem sie Treuhänderin und alleinige Begünstigte ist, weitere 1,876 Aktien. Das Filing identifiziert den Verkauf als Teil eines am 02/03/2025 angenommenen Plans und ist am 10/08/2025 von einem Bevollmächtigten unterzeichnet. Die Transaktion wird als routinemäßige Insider-Veräußerung im Rahmen eines dokumentierten Handelsplans dargestellt.

كانت مديرة تيرادين، ميرِدِس جونسون، قد أبلغت عن بيع أسهم الشركة ضمن خطة محددة سلفاً وتحتفظ بحصة كبيرة. تُظهر الإيداع عملية بيع بسعر $147.9 للسهم من 625 سهمًا في 10/06/2025، تمت بموجب خطة بيع Rule 10b5-1. بعد البيع، تمتلك جهة الإبلاغ بشكل مباشر 10,113 سهمًا وبشكل غير مباشر عبر صندوق ائتماني تشغله كمسؤولة ائتمانية وربما كمعنيّة وحيدة بالمستفيدين 1,876 سهمًا. يحدد الإيداع أن البيع جزء من خطة اعتمدت في 02/03/2025، وموقع من وكيل في 10/08/2025. يتم تقديم المعاملة كتصرف داخلي روتيني وفقاً لخطة تداول موثقة.

Teradyne 的董事 Mercedes Johnson 透过预设计划出售公司股份,且仍持有显著股份。 文件显示在 2025-10-06 以每股 $147.9 的价格出售 625 股,按 Rule 10b5-1 的交易计划执行。出售后,申报人直接持有 10,113 股、通过她担任受托人并为唯一受益人的信托间接持有 1,876 股。 文件将该出售标识为在 2025-02-03 通过的计划的一部分,并在 2025-10-08 由授权代理人签署。该交易被呈现为在记录在案的交易计划下的日常内幕交易处置。

Positive
  • Sale executed under a documented Rule 10b5-1 plan, which provides structural compliance protections
  • Reporting person retains material ownership: 10,113 shares direct plus 1,876 shares indirect via trust
Negative
  • Insider disposition occurred: 625 shares sold at $147.9, which modestly reduces direct holdings

Insights

Insider sale via a documented 10b5-1 plan; ownership remains material.

The director sold 625 shares at $147.9 on 10/06/2025 under a 10b5-1 plan adopted on 02/03/2025, which provides an affirmative defense to insider trading claims when properly implemented.

Remaining holdings show continued alignment: 10,113 shares direct and 1,876 indirect by trust. Watch for additional scheduled plan disclosures or further Form 4 filings within the next quarter if the plan contains ongoing sales.

Transaction size is modest relative to typical director stakes but is price-sensitive.

A sale of 625 shares is a discrete liquidity event; the filing documents the sale price and that it occurred under a pre-existing plan, which reduces signal strength about private information.

Investors tracking insider activity should note the exact price $147.9 and the plan adoption 02/03/2025; any repeat filings at similar prices could indicate systematic disposition timing over the coming months.

La direttrice di Teradyne, Mercedes Johnson, ha riportato una vendita di azioni della società nell'ambito di un piano predefinito e mantiene una quota significativa. Il fascicolo mostra una vendita di $147.9 per azione di 625 azioni il 10/06/2025, eseguita nell'ambito di un piano di vendita Rule 10b5-1. Dopo la vendita la persona che segnala beneficia direttamente di 10,113 azioni e indirettamente di 1,876 azioni tramite un trust di cui è trustee e unico beneficiario. Il fascicolo identifica la vendita come parte di un piano adottato il 02/03/2025, ed è firmato da un procuratore in rappresentanza il 10/08/2025. L'operazione viene presentata come disposizione interna di routine nell'ambito di un piano di trading documentato.

La Directora de Teradyne, Mercedes Johnson, reportó la venta de acciones de la empresa bajo un plan preestablecido y mantiene una participación significativa. La presentación muestra la venta de $147.9 por acción de 625 acciones el 10/06/2025, realizada bajo un plan de ventas Rule 10b5-1. Después de la venta, la persona reportante posee de forma beneficiosa 10,113 acciones directamente y 1,876 acciones indirectamente a través de un fideicomiso del cual es fideicomitente y único beneficiario. El documento identifica la venta como parte de un plan adoptado el 02/03/2025, y está firmado por un apoderado en la fecha 10/08/2025. La transacción se presenta como una disposición interna de rutina bajo un plan de trading documentado.

테라다인(Teradyne)의 이사인 메르세데스 존슨(Mercedes Johnson)은 미리 정해진 계획에 따라 회사 주식을 매도했고 상당한 지분을 보유하고 있습니다. 공시는 $147.9당의 매도가 625 주로 2025-10-06에 Rule 10b5-1 매매 계획에 따라 실행되었음을 보여줍니다. 매도 후 보고자는 10,113 주를 직접 보유하고, 1,876 주를 트러스트를 통해 간접 보유하며, 그 트러스트의 수탁자이자 유일한 수익자입니다. 이 공시는 매도가 2025-02-03에 채택된 계획의 일부로 식별되며, 2025-10-08에 대리인이 서명했습니다. 이 거래는 문서화된 거래 계획에 따른 일상적 내부자 매도(disposition)로 제시됩니다.

La directrice de Teradyne, Mercedes Johnson, a signalé la vente d'actions de l'entreprise dans le cadre d'un plan prédéfini et conserve une participation importante. Le dossier indique une vente à $147.9 par action de 625 actions le 10/06/2025, réalisée dans le cadre d'un plan de vente Rule 10b5-1. Après la vente, la personne déclarant détient directement 10,113 actions et indirectement via une fiducie dont elle est fiduciaire et unique bénéficiaire 1,876 actions. Le dossier identifie la vente comme faisant partie d'un plan adopté le 02/03/2025, et elle est signée par un mandataire le 10/08/2025. La transaction est présentée comme une disposition interne routinière dans le cadre d'un plan de trading documenté.

Die Teradyne-Direktorin Mercedes Johnson berichtete über den Verkauf von Unternehmensaktien im Rahmen eines vorgegebenen Plans und behält eine bedeutende Beteiligung. Die Einreichung zeigt einen Verkauf von $147.9 pro Aktie von 625 Aktien am 10/06/2025, der im Rahmen eines Rule-10b5-1-Verkaufplans durchgeführt wurde. Nach dem Verkauf besitzt die meldende Person direkt 10,113 Aktien und indirekt über einen Trust, bei dem sie Treuhänderin und alleinige Begünstigte ist, weitere 1,876 Aktien. Das Filing identifiziert den Verkauf als Teil eines am 02/03/2025 angenommenen Plans und ist am 10/08/2025 von einem Bevollmächtigten unterzeichnet. Die Transaktion wird als routinemäßige Insider-Veräußerung im Rahmen eines dokumentierten Handelsplans dargestellt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JOHNSON MERCEDES

(Last) (First) (Middle)
C/O TERADYNE, INC.
600 RIVERPARK DRIVE

(Street)
NORTH READING MA 01864

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TERADYNE, INC [ TER ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/06/2025 S(1) 625 D $147.9 10,113 D
Common Stock 1,876 I By Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 3, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
2. Shares held by The Mercedes Johnson Trust UAD 07/23/04 (the "Trust"), of which the Reporting Person is the trustee and sole beneficiary.
/s/ Ryan E. Driscoll, Attorney-in-Fact 10/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Mercedes Johnson report on the TER Form 4?

The filing reports a sale of 625 shares at $147.9 on 10/06/2025 executed under a 10b5-1 plan; post-transaction holdings are 10,113 direct shares and 1,876 indirect shares.

Was the sale part of a pre-arranged trading plan for TER insiders?

Yes. The sale was made pursuant to a sales plan adopted on 02/03/2025 intended to comply with Rule 10b5-1.

How much ownership does the reporting person retain after the sale?

After the reported transaction the reporting person beneficially owns 10,113 shares directly and 1,876 shares indirectly via The Mercedes Johnson Trust UAD 07/23/04.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Ryan E. Driscoll, Attorney-in-Fact on 10/08/2025.

Does the filing indicate any derivative transactions?

No. Table II for derivative securities shows no entries; only non-derivative common stock transactions are reported.
Teradyne

NASDAQ:TER

TER Rankings

TER Latest News

TER Latest SEC Filings

TER Stock Data

23.00B
158.62M
0.27%
104.15%
4.46%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
NORTH READING